BALVEEN SINGH: Open Payments
NPI 1164753745 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,385 in 207 payments from 16 companies in 2025. Trend: 2023 $39,922 · 2024 $76,371 · 2025 $66,385
Honoraria: $30,840Speaker / faculty: $19,953Travel & lodging: $10,917Food & beverage: $4,675
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 59 | $38,938 |
| Otsuka America Pharmaceutical, Inc. | 37 | $25,326 |
| Neurocrine BioSciences, Inc. | 16 | $437 |
| ABBVIE INC. | 28 | $329 |
| E.R. Squibb & Sons, L.L.C. | 17 | $296 |
| Alkermes, Inc. | 20 | $286 |
| Janssen Pharmaceuticals, Inc | 6 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $157 |
| Boston Scientific Corporation | 8 | $147 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
Products named: Auvelity, REXULTI, INGREZZA, VRAYLAR, COBENFY, ARISTADA, ABILIFY MAINTENA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
